OrangeTrader93

Marathon Oil Entry

Long
NYSE:MRO   Marathon Oil Corporation
//Targeting Metrics//
Bullish Elliot Wave will end at ~$20 on 01DEC2022

Marathon Oil has taken steps to improve earnings by cutting cost for the year 2021, that which is reflected after analyzing and comparing this company’s financials quarter-to-quarter. MRO currently benchmarks in the 91st percentile in the crude petroleum and natural gas sector. MRO’s share price has been moving downward since 01JUL2021 in tandem with a falling price-to-book ratio from 1.047 to 0.856 in confluence with a PEG ratio of .30, indicating that Marathon Oil is undervalued and can be expected to increase earnings. The beta value is currently at 3.23, indicating MRO’s movement is three times faster than the current market.
Although share price has been moving downwards, the RSI (at seven-day intervals) hasn’t dropped below fifty percent on the weekly and monthly intervals while also bullish divergence can be seen on the weekly time frame, thus indicating continued bullish fervor. ATR is also divergent on the 4H interval from this stock’s downward trend since 28MAY2021, indicating a sentiment for a major bullish capitulation.
Share price has been consolidating below the 200 EMA on the 1D interval since 20JUL2021. Bullish capitulation will hinge on a positive earnings report on 03AUG2021 with continued bidding.
Comment:
*CORRECTION*
Share price is consolidating below the 200 EMA on the weekly interval not the daily.

Earnings report will be released on 05AUG2021. I sourced the date posted from the TradingView platform. Note to self : go straight to the source next time.
Trade active:
Target 1 : 15.43
Comment:
//Release 04AUG2021//
The actual EPS is officially 0.23 for Q2.

Revenue is up 14.45% to 1.18B from 831M
Net Income is up an astronomical 310% to 97M -338M
Net Change in Cash is up 1034.15% to 383M from -377M
Cost of Revenue us down 10.2% to 273M from 301M
Comment:
Advanced Price Target : 12.61
Trade closed: target reached:
Happy trading.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.